ManageEngine RecoveryManager Plus
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
Comparison · Analytics
ApexCharts vs pharmaversesdtm
A side-by-side editorial comparison of ApexCharts and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
ApexCharts vs pharmaversesdtm: at a glance
What is ApexCharts?
Licensing settled, ApexCharts is back to changing what a chart can take as input.
ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.
What is pharmaversesdtm?
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
ApexCharts vs pharmaversesdtm: editorial side-by-side
ApexCharts
10.0ANALYTICS
Licensing settled, ApexCharts is back to changing what a chart can take as input.
◆ Current state
ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.
◆ Where it's heading
The through-line now is input and arrangement rather than catalogue size. Charts increasingly accept the measurements a team actually has instead of pre-aggregated values, and the seams that let you hand a chart its own layout — plotOptions.unit.positions, the pluggable layout hook — are being filled in with kits rather than hard-coded options. The premium boundary has stopped moving; the free catalogue keeps growing around it.
◆ Prediction
Expect the raw-observation pattern to reach another chart type now that the bar pathway handles binning, and expect the remaining pluggable seams to get companion kits the way positions just did.
pharmaversesdtm
0.0ANALYTICS
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
◆ Current state
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
◆ Where it's heading
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
◆ Prediction
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Alternatives to ApexCharts and pharmaversesdtm
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ApexCharts or pharmaversesdtm.
Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
silx
silx settles into maintenance a release after its PySide6 migration
Plotly
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread
aniread stops asking you to know which tracker wrote the file
Rho
Rho's release machinery finally produced a stable build — and it shipped no new product.
See all ApexCharts alternatives → · See all pharmaversesdtm alternatives →
Recent activity from ApexCharts and pharmaversesdtm
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1d agoApexChartsUnit charts get a 39-shape companion kit
- 2d agoApexChartsHistogram bins raw samples; charts morph between types ⚡
- 9d agoApexChartsPer-data-point label offsets land as functions
- 10d agoApexChartsPie and donut slice clicks work again after a 6.7.0 regression
- 17d agoApexChartsSunburst charts arrive; premium features now need an entitled plan ⚡
- 22d agoApexChartsUnit chart is the first premium-gated chart type ⚡
- 1mo agopharmaversesdtmLymphoma response data and geographic-atrophy tests
- 4mo agopharmaversesdtmCSV exports and microbiology domains for wider access
- 7mo agopharmaversesdtmNeurological SDTM datasets and Alzheimer's biomarkers
- 0y agopharmaversesdtmMaintainer and licensing update
- 1y agopharmaversesdtmMetabolic SDTM datasets and PCWG3 oncology response
- 1y agopharmaversesdtmGCIG response data and automated reference pages
Frequently asked questions
What is the difference between ApexCharts and pharmaversesdtm?
They serve adjacent needs but don't currently overlap on shipped themes. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 0.0), with 3 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is ApexCharts better than pharmaversesdtm?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 0.0), with 3 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to ApexCharts?
Top ApexCharts alternatives in Analytics are ranked by recent ship velocity. Browse the "ApexCharts alternatives" section above for the current picks, or visit /alternatives/apexcharts for the full list with editorial commentary on each.
What are the best alternatives to pharmaversesdtm?
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.